Screen Holdings (TYO:7735) has an average rating of overweight and mean price target of 12,403.12 yen, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Hansoh Pharmaceutical's (HKG:3692) obtained clinical trial approval for its HS-10541 tablets from China's National Medical Products Administration, according to a Wednesday Hong Kong bourse filing.Shares of the pharma firm were down over 1% in Thursday afternoon trading.The trial will study the drug for the treatment of patients with KRAS G12C-mutated advanced solid tumors.
Shanghai Kehua Bio-Engineering's (SHE:002022) unit, Suzhou Tianlong Biotechnology, received a medical device registration certificate from China's National Medical Products Administration for a swab kit for metapneumovirus nucleic acid, according to a Shenzhen bourse filing on Thursday.The certificate for the human metapneumovirus nucleic acid detection kit is valid until May 10, 2031.The Chinese in vitro diagnostics company's shares fell 2% during the afternoon trade.
CTBC Financial (TPE:2891) booked a consolidated net profit of NT$5.40 billion for April, with pre-tax income of NT$6.58 billion, or according to a Thursday Taiwan Exchange filing.For the first four months of 2026, the group recorded an attribuatble net profit of NT$28.5 billion, or NT$1.46 per share.Meanwhile, cumulativewhile pre-tax income came in at NT$34.9 billion, the filing said.